AD is characterized by the accumulation of beta-amyloid (Aß) plaques as well as the deposition of aggregates of hyperphosphorylated tau (ptau) as NFTs, however in AD there is no accentuation of ptau deposition around small blood vessels and there are differences in the tau epitopes expressed in AD and CTE [8]. The gene discussed is MAPT; the disease is Alzheimer disease.